Activity List
-
Eisai was Awarded Certificate of Appreciation by the National Department of Health of Papua New Guinea for Eisai’s Support towards COVID-19
August 30, 2021
-
Lymphatic Filariasis Elimination Activities in Papua New Guinea
Eisai Donated Masks and Gloves for COVID-19 Countermeasures in Mass Drug AdministrationJuly 2, 2021
-
Activities for Lymphatic Filariasis Elimination in Kenya
February 19, 2021
Current Distribution Status of DEC Tablets for Endemic Countries
2.05 billion tablets for 29 countries
as of April 2022
- In November 2010, Eisai agreed to provide 2.2 billion DEC (diethylcarbamazine) tablets free of charge through WHO to lymphatic filariasis endemic countries worldwide by 2020
- In August 2013, Eisai's DEC tablets obtained prequalification from WHO, the first Neglected Tropical Disease treatment to receive prequalification in the world
- In October 2013, DEC tablet provision commenced from our Vizag plant
- In April 2017, Eisai announced that it would continue to provide DEC tablets to endemic countries that need them beyond 2020, until complete elimination is achieved
Countries where DEC tablets are supplied and countries where lymphatic filariasis (LF) is eliminated
● Countries where distribution has commenced
Countries where LF is eliminated

LF elimination was achieved in Egypt, Kiribati, Thailand and Sri Lanka out of 29 countries, where Eisai has provided DEC tablets.
-
September 1, 2020
-
February 13, 2020
DEC Project Managers' Efforts to Support Lymphatic Filariasis Elimination Activities
-
December 11, 2018
Previous Articles
-
November 12, 2018
-
April 20, 2017
-
January 20, 2017
-
June 3, 2016
Creating Leaflet for DEC Tablets in Local Languages for Endemic Countries
-
March 18, 2016
Reaching the 2 Billion: The Japanese Pharmaceutical Industry's Contributions to Access to Medicine
-
February 17, 2016
Eisai's Involvement in New Partnership to Provide Diagnostic Kits for Lymphatic Filariasis
-
February 10, 2016
DEC Project Managers' Efforts to Support Lymphatic Filariasis Elimination Activities in Indonesia
-
February 20, 2015
Eliminating Lymphatic Filariasis and Other Neglected Tropical Diseases (NTDs) by 2020
-
January 27, 2015
Evaluating Eisai's Efforts to Improve Access to Medicines #2 -The ATM Index Ranking 2014-
-
March 27, 2014
Eisai's Challenge of Greater Access to Medicines: Tackling Lymphatic Filariasis (video presentation)
-
February 17, 2014
Evaluating Eisai's Efforts to Improve Access to Medicines -The ATM Index Ranking-
-
November 18, 2013
-
September 2, 2013
-
November 7, 2012
The First Shipment of DEC Tablets to WHO in Effort to Help Eliminate Lymphatic Filariasis
-
August 20, 2012
London Declaration-Eisai Increases its Commitment to Fight Neglected Tropical Diseases
-
June 29, 2011
Our Activities
- Initiatives for Lymphatic Filariasis
An Overview of the Distribution Status of Lymphatic Filariasis Treatment to Endemic Countries and Disease Elimination Activities
An Overview of Business Activities for Improving Access to Medicines in Emerging and Developing Countries
An Overview of R & D Activities Related to the Three Major Infectious Diseases and Neglected Tropical Diseases